{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T23:12:35Z","timestamp":1768864355779,"version":"3.49.0"},"reference-count":51,"publisher":"Societatea Romana de Morfologie","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rom J Morphol Embryol"],"published-print":{"date-parts":[[2025,12,12]]},"abstract":"<jats:p>Pituitary neuroendocrine tumors (PitNETs), as the old pituitary adenomas are now defined, represent almost 15% of all intracranial neoplasms. Their particularity consists in considerable morphological and functional heterogeneity. Although mostly benign, PitNETs may coexist with systemic malignancies. The aim of this research was to identify possible associations between PitNETs and prior extrapituitary cancers in a series of patients in order to identify common mechanisms between pituitary and systemic pathology because such associations, although rare, are clinicopathologically significant, raising issues of differential diagnosis and therapeutic strategy. We realized a retrospective descriptive study on six patients diagnosed with PitNETs and a documented history of extrapituitary malignancy, surgically treated at Prof. Dr. Nicolae Oblu Emergency Clinical Hospital, Ia\u015fi, Romania, between January 2023 and June 2025. Clinical, imaging, and pathological data were collected. Immunohistochemical profile included synaptophysin, cytokeratins, transcription factors [pituitary-specific transcription factor-1 (Pit1), T-box transcription factor 19 (Tpit; Tbx19), steroidogenic factor-1 (SF-1), and pituitary GATA-binding protein 3 (GATA3)], hormonal markers [growth hormone (GH), prolactin (PRL), adrenocorticotropic hormone (ACTH), luteinizing hormone (LH), follicle-stimulating hormone (FSH), and thyroid-stimulating hormone (TSH)], as well as proliferative indices [p53 and Ki67 labeling index (LI)]. The study group comprised four women and two men (mean age 52.7 years). The most frequently associated malignancies were breast carcinoma (BC) and renal cell carcinoma (RCC) (33.3% each), followed by thyroid carcinoma (TC) and hepatocellular carcinoma (HCC) (16.6% each). PitNET subtypes included somatotroph (50%), lactotroph (16.6%), gonadotroph (16.6%), and plurihormonal (16.6%) variants, predominantly microadenomas (83.3%). The mean interval between the two diagnoses was 1632 days (\u22484.6 years). GH and PRL immunopositivity predominate in cases with BC, RCC, and TC. Proliferative indices were low (Ki67  4%), except for one lactotroph PitNET (Ki67 LI: 15%, p53: 20%) associated with HCC. This study highlights a potential bidirectional link between pituitary and systemic tumorigenesis mediated by hormonal and proliferative signaling pathways. The predominance of GH\/PRL-secreting PitNETs in patients with prior systemic malignancies supports the hypothesis of endocrine and molecular crosstalk through the GH\/insulin-like growth factor-1 (IGF-1) axis. Although causality cannot be established, these findings underscore the need for oncological surveillance and endocrine monitoring in patients with PitNETs, especially in those with a previous malignancy.<\/jats:p>","DOI":"10.47162\/rjme.66.3.08","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T10:41:45Z","timestamp":1768819305000},"page":"511-522","source":"Crossref","is-referenced-by-count":0,"title":["Pituitary neuroendocrine tumors in patients with prior extrapituitary cancer \u2013 clinical and immunohistochemical insights into a complex association. Evidence from a retrospective series"],"prefix":"10.47162","volume":"66","author":[{"name":"Department of Morphofunctional Sciences I, Grigore T. Popa University of Medicine and Pharmacy, Ia\u015fi, Romania","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana-Marina","family":"R\u0103dulescu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Drago\u015f Viorel","family":"Scripcariu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Surgery I, Grigore T. Popa University of Medicine and Pharmacy, Ia\u015fi, Romania; 1st Surgical Oncology Unit, Regional Institute of Oncology, Ia\u015fi, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana-Maria","family":"Dumitrescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Morphofunctional Sciences I, Grigore T. Popa University of Medicine and Pharmacy, Ia\u015fi, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Ilie","family":"Rotariu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Surgery II, Grigore T. Popa University of Medicine and Pharmacy, Ia\u015fi, Romania; 2nd Neurosurgery Clinic, Prof. Dr. Nicolae Oblu Emergency Clinical Hospital, Ia\u015fi, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Scripcaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Morphofunctional Sciences I, Grigore T. Popa University of Medicine and Pharmacy, Ia\u015fi, Romania; Laboratory of Pathology, Prof. Dr. Nicolae Oblu Emergency Clinical Hospital, Ia\u015fi, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucian","family":"Eva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"2nd Neurosurgery Clinic, Prof. Dr. Nicolae Oblu Emergency Clinical Hospital, Ia\u015fi, Romania; Doctoral School, Lower Danube University of Gala\u0163i, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marius Gabriel","family":"Dabija","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Surgery II, Grigore T. Popa University of Medicine and Pharmacy, Ia\u015fi, Romania; 1st Neurosurgery Clinic, Prof. Dr. Nicolae Oblu Emergency Clinical Hospital, Ia\u015fi, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corina","family":"Ciupilan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Morphofunctional Sciences I, Grigore T. Popa University of Medicine and Pharmacy, Ia\u015fi, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anca","family":"Sava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Morphofunctional Sciences I, Grigore T. Popa University of Medicine and Pharmacy, Ia\u015fi, Romania; Laboratory of Pathology, Prof. Dr. Nicolae Oblu Emergency Clinical Hospital, Ia\u015fi, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela Floren\u0163a","family":"Dumitrescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Laboratory of Pathology, Prof. Dr. Nicolae Oblu Emergency Clinical Hospital, Ia\u015fi, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristinel Ionel","family":"Stan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Morphofunctional Sciences I, Grigore T. Popa University of Medicine and Pharmacy, Ia\u015fi, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"26736","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"ref0","unstructured":"\"[1] Asa SL, Osamura RY, Mete O. Pituitary tumours: introduction. In: World Health Organization (WHO) Classification of Tumours Editorial Board. Endocrine and neuroendocrine tumours. WHO Classification of Tumours Series, 5th edition, vol. 10, International Agency for Research on Cancer (IARC) Press, Lyon, France, 2025."},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"[2] Chen Y, Wang CD, Su ZP, Chen YX, Cai L, Zhuge QC, Wu ZB. Natural history of postoperative nonfunctioning pituitary adenomas: a systematic review and meta-analysis. Neuroendocrinology, 2012, 96(4):333-342. https:\/\/doi.org\/10.1159\/000339823","DOI":"10.1159\/000339823"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"[3] Biermasz NR. The burden of disease for pituitary patients. Best Pract Res Clin Endocrinol Metab, 2019, 33(2):101309. https:\/\/doi.org\/10.1016\/j.beem.2019.1013092","DOI":"10.1016\/j.beem.2019.101309"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"[4] Osorio RC, Oh JY, Choudhary N, Lad M, Savastano L, Aghi MK. Pituitary adenomas and cerebrovascular disease: a review on pathophysiology, prevalence, and treatment. Front Endocrinol (Lausanne), 2022, 13:1064216. https:\/\/doi.org\/10.3389\/fendo.2022.1064216","DOI":"10.3389\/fendo.2022.1064216"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"[5] Krzentowska A, Czepko R, Adamek D, Filipowicz M, Broniatowska E, Go\u0142kowski F. Radiological and immunohistochemical characteristics of PitNETs in 79 patients undergoing neurosurgery. Cancers (Basel), 2025, 17(4):666. https:\/\/doi.org\/10.3390\/cancers17040666","DOI":"10.3390\/cancers17040666"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"[6] Saeger W, Mawrin C, Meinhardt M, Wefers AK, Jacobsen F. Two pituitary neuroendocrine tumors (PitNETs) with very high proliferation and TP53 mutation - high-grade PitNET or PitNEC? Endocr Pathol, 2022, 33(2):257-262. https:\/\/doi.org\/10.1007\/s12022-021-09693-y","DOI":"10.1007\/s12022-021-09693-y"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"[7] Mete O, Asa SL. Clinicopathological correlations in pituitary adenomas. Brain Pathol, 2012, 22(4):443-453. https:\/\/doi.org\/10.1111\/j.1750-3639.2012.00599.x","DOI":"10.1111\/j.1750-3639.2012.00599.x"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"[8] Yoon JH, Choi W, Park J Y, Hong AR, Kim SS, Kim HK, Kang HC. A challenging TSH\/GH co-secreting pituitary adenoma with concomitant thyroid cancer; a case report and literature review. BMC Endocr Disord, 2021, 21(1):177. https:\/\/doi.org\/10.1186\/s12902-021-00839-x","DOI":"10.1186\/s12902-021-00839-x"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"[9] Schaer JC, Waser B, Mengod G, Reubi JC. Somatostatin receptor subtypes sst1, sst2, sst3 and sst5 expression in human pituitary, gastroenteropancreatic and mammary tumors: comparison of mRNA analysis with receptor autoradiography. Int J Cancer, 1997, 70(5):530-537. https:\/\/doi.org\/10.1002\/(sici)1097-0215(19970304)70:5<530::aid-ijc7>3.0.co;2-z","DOI":"10.1002\/(SICI)1097-0215(19970304)70:5<530::AID-IJC7>3.0.CO;2-Z"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"[10] Renehan AG, Brennan BM. Acromegaly, growth hormone and cancer risk. Best Pract Res Clin Endocrinol Metab, 2008, 22(4):639-657. https:\/\/doi.org\/10.1016\/j.beem.2008.08.011","DOI":"10.1016\/j.beem.2008.08.011"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"[11] Loeper S, Ezzat S. Acromegaly: re-thinking the cancer risk. Rev Endocr Metab Disord, 2008, 9(1):41-58. https:\/\/doi.org\/10.1007\/s11154-007-9063-z","DOI":"10.1007\/s11154-007-9063-z"},{"key":"ref11","unstructured":"[12] Costache II, Costea CF, Danciu M, Costan VV, Aursulesei V, Dumitrescu GF, Turliuc MD, Sava A. Amyloidosis - a rare cause of refractory heart failure in a young female. Rom J Morphol Embryol, 2017, 58(1):201-206."},{"key":"ref12","unstructured":"[13] Costea CF, Anghel K, Dimitriu G, Dumitrescu GF, Faiyad Z, Dumitrescu AM, Sava A. Anatomoclinical aspects of conjunctival malignant metastatic melanoma. Rom J Morphol Embryol, 2014, 55(3):933-937."},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"[14] Trif\u0103nescu RA, Dal J. Editorial: Cancer risk in patients with acromegaly - is extensive screening needed? Front Endocrinol (Lausanne), 2024, 15:1503633. https:\/\/doi.org\/10.3389\/fendo.2024.1503633","DOI":"10.3389\/fendo.2024.1503633"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"[15] Xiao Z, Xiao P, Wang Y, Fang C, Li Y. Risk of cancer in acromegaly patients: an updated meta-analysis and systematic review. PLoS One, 2023, 18(11):e0285335. https:\/\/doi.org\/10.1371\/journal.pone.0285335","DOI":"10.1371\/journal.pone.0285335"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"[16] Pekic S, Stojanovic M, Popovic V. Pituitary tumors and the risk of other malignancies: is the relationship coincidental or causal? Endocr Oncol, 2022, 2(1):R1-R13. https:\/\/doi.org\/10.1530\/EO-21-0033","DOI":"10.1530\/EO-21-0033"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"[17] Hemminki K, F\u00f6rsti A, Ji J. Incidence and familial risks in pituitary adenoma and associated tumors. Endocr Relat Cancer, 2007, 14(1):103-109. https:\/\/doi.org\/10.1677\/ERC-06-0008","DOI":"10.1677\/ERC-06-0008"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"[18] Danilowicz K, Sosa S. Acromegaly and cancer: an update. Arch Med Res, 2023, 54(8):102914. https:\/\/doi.org\/10.1016\/j.arcmed.2023.102914","DOI":"10.1016\/j.arcmed.2023.102914"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"[19] Wen G, Tang C, Zhong C, Li J, Cong Z, Zhou Y, Liu K, Zhang Y, Tohti M, Ma C. One-and-a-half nostril endoscopic trans-sphenoidal approach for pituitary adenomas - a technical report. J Otolaryngol Head Neck Surg, 2016, 45(1):60. https:\/\/doi.org\/10.1186\/s40463-016-0174-y","DOI":"10.1186\/s40463-016-0174-y"},{"key":"ref19","unstructured":"[20] Istrate-Ofi\u0163eru AM, Pirici D, Niculescu M, Berceanu C, Berceanu S, Voicu NL, Piring\u0103 GD, Ro\u015fu GC, Iovan L, C\u0103pit\u0103nescu RG, Di\u0163escu D, Sava A, Mogoant\u0103 L, Neac\u015fu A. Clinical, morphological and immunohistochemical survey in different types of endometriosis. Rom J Morphol Embryol, 2018, 59(4):1133-1153."},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"[21] Marin F, Kovacs KT, Scheithauer BW, Young WF Jr. The pituitary gland in patients with breast carcinoma: a histologic and immunocytochemical study of 125 cases. Mayo Clin Proc, 1992, 67(10):949-956. https:\/\/doi.org\/10.1016\/s0025-6196(12)60925-2","DOI":"10.1016\/S0025-6196(12)60925-2"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"[22] Battistone MF, Miragaya K, Rogozinski A, Ag\u00fcero M, Alfieri A, Ballarino MC, Boero L, Danilowicz K, Diez S, Donoso M, Fainstein-Day P, Furioso A, Garcia-Basavilbaso N, Glerean M, Katz D, Loto M, Mallea-Gil S, Martinez M, Sabate MI, Servidio M, Slavinsky P, Stalldecker G, Sosa S, Szuman G, Tkatch J, Caldo I, Lubieniecki D, Guitelman M. Increased risk of preneoplastic colonic lesions and colorectal carcinoma in acromegaly: multicenter case-control study. Pituitary, 2021, 24(1):96-103. https:\/\/doi.org\/10.1007\/s11102-020-01090-8","DOI":"10.1007\/s11102-020-01090-8"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"[23] Kim YS, Yun JS, Kim H, Jeun SS, Kim B, Lee SW, Lee JE, Kim K, Ko SH, Ahn YB, Han K, Yang SH. Acromegaly and the risk of cancer: a nationwide population-based cohort study in Korea. Eur J Endocrinol, 2025, 192(3):220-227. https:\/\/doi.org\/10.1093\/ejendo\/lvaf029","DOI":"10.1093\/ejendo\/lvaf029"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"[24] Terzolo M, Puglisi S, Reimondo G, Dimopoulou C, Stalla GK. Thyroid and colorectal cancer screening in acromegaly patients: should it be different from that in the general population? Eur J Endocrinol, 2020, 183(4):D1-D13. https:\/\/doi.org\/10.1530\/EJE-19-1009","DOI":"10.1530\/EJE-19-1009"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"[25] Buchholz S, Seitz S, Schally AV, Engel JB, Rick FG, Szalontay L, Hohla F, Krishan A, Papadia A, Gaiser T, Brockhoff G, Ortmann O, Diedrich K, K\u00f6ster F. Triple-negative breast cancers express receptors for luteinizing hormone-releasing hormone (LHRH) and respond to LHRH antagonist Cetrorelix with growth inhibition. Int J Oncol, 2009, 35(4):789-796. https:\/\/doi.org\/10.3892\/ijo_00000391","DOI":"10.3892\/ijo_00000391"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"[26] Terzolo M, Reimondo G, Berchialla P, Ferrante E, Malchiodi E, De Marinis L, Pivonello R, Grottoli S, Losa M, Cannavo S, Ferone D, Montini M, Bondanelli M, De Menis E, Martini C, Puxeddu E, Velardo A, Peri A, Faustini-Fustini M, Tita P, Pigliaru F, Peraga G, Borretta G, Scaroni C, Bazzoni N, Bianchi A, Berton A, Serban AL, Baldelli R, Fatti LM, Colao A, Arosio M; Italian Study Group of Acromegaly. Acromegaly is associated with increased cancer risk: a survey in Italy. Endocr Relat Cancer, 2017, 24(9):495-504. https:\/\/doi.org\/10.1530\/ERC-16-0553","DOI":"10.1530\/ERC-16-0553"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"[27] Dal J, Leisner MZ, Hermansen K, Farkas DK, Bengtsen M, Kistorp C, Nielsen EH, Andersen M, Feldt-Rasmussen U, Dekkers OM, S\u00f8rensen HT, J\u00f8rgensen JOL. Cancer incidence in patients with acromegaly: a cohort study and meta-analysis of the literature. J Clin Endocrinol Metab, 2018, 103(6):2182-2188. https:\/\/doi.org\/10.1210\/jc.2017-02457","DOI":"10.1210\/jc.2017-02457"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"[28] Esposito D, Ragnarsson O, Johannsson G, Olsson DS. Incidence of benign and malignant tumors in patients with acromegaly is increased: a nationwide population-based study. J Clin Endocrinol Metab, 2021, 106(12):3487-3496. https:\/\/doi.org\/10.1210\/clinem\/dgab560","DOI":"10.1210\/clinem\/dgab560"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"[29] Arlien-S\u00f8borg MC, Dal J, Heck A, Stochholm K, Husted E, Feltoft CL, Rasmussen \u00c5K, Feldt-Rasmussen U, Andreassen M, Klose MC, Nielsen TL, Andersen MS, Christensen LL, Krogh J, Jarlov A, Bollerslev J, Nermoen I, Oksnes M, Dahlqvist P, Olsson T, Berinder K, Hoybye C, Petersson M, Akerman AK, Wahlberg J, Ekman B, Engstrom BE, Johannsson G, Ragnarsson O, Olsson D, Sigurj\u00f3nsd\u00f3ttir H\u00c1, Fougner SL, Matikainen N, Vehkavaara S, Metso S, Jaatinen P, H\u00e4m\u00e4l\u00e4inen P, Rintam\u00e4ki R, Yliaska I, Immonen H, M\u00e4kimattila S, Cederberg-Tamminen H, Viukari M, Nevalainen P, Nuutila P, Schalin-J\u00e4ntti C, Burman P, J\u00f8rgensen JOL. Acromegaly management in the Nordic countries: a Delphi consensus survey. Clin Endocrinol (Oxf), 2024, 101(3):263-273. https:\/\/doi.org\/10.1111\/cen.15095","DOI":"10.1111\/cen.15095"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"[30] Kresovich JK, Guranich C, Houghton S, Qian J, Jones ME, Boutot ME, Dowsett M, Eliassen AH, Garcia-Closas M, Kraft P, Norman A, Pollak M, Rinaldi S, Rosner B, Schoemaker MJ, Scott C, Swerdlow AJ, Milne RL, Tworoger SS, Vachon CM, Hankinson SE. Plasma prolactin and postmenopausal breast cancer risk: a pooled analysis of four prospective cohort studies. Breast Cancer Res, 2024, 26(1):169. https:\/\/doi.org\/10.1186\/s13058-024-01922-6","DOI":"10.1186\/s13058-024-01922-6"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"[31] Dekkers OM, Romijn JA, de Boer A, Vandenbroucke JP. The risk for breast cancer is not evidently increased in women with hyperprolactinemia. Pituitary, 2010, 13(3):195-198. https:\/\/doi.org\/10.1007\/s11102-009-0214-y","DOI":"10.1007\/s11102-009-0214-y"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"[32] Saratziotis A, Baldovin M, Zanotti C, Munari S, Denaro L, Hajiioannou J, Emanuelli E. Outcomes of the transsphenoidal approach for ACTH-secreting pituitary tumours and the role of postoperative ACTH in predicting the late recurrence of Cushing's disease: a retrospective analysis of 50 cases. Healthcare (Basel), 2025, 13(12):1395. https:\/\/doi.org\/10.3390\/healthcare13121395","DOI":"10.3390\/healthcare13121395"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"[33] Dumitrescu AM, Eva L, Haba D, Cucu AI, Dumitrescu GF, Burduloi VM, Dima-Cozma LC, Vatavu R, Moro\u015fanu GC, Sava A. Anatomical study of circle of Willis on fresh autopsied brains. A study of a Romanian population. Rom J Morphol Embryol, 2022, 63(2):395-406. https:\/\/doi.org\/10.47162\/RJME.63.2.10","DOI":"10.47162\/RJME.63.2.10"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"[34] Dumitrescu AM, Chiran DA, Stan CI, Paraschiv CM, Dobrin N, Chiriac A, Leon MM, Dima-Cozma LC, Dascalu CG, Radulescu AM, Gavril RF, Sava A. Comparing antemortem CT-angiography data with autopsy findings in regard to anterior communicating artery aneurysms. NeuroSci, 2025, 6(3):81. https:\/\/doi.org\/10.3390\/neurosci6030081","DOI":"10.3390\/neurosci6030081"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"[35] Zheng H, Kang H, Qiu Y, Xie L, Wu J, Lai P, Kang J. Novel PRKAR1A mutation in Carney complex: a case report and literature review. Front Endocrinol (Lausanne), 2024, 15:1384956. https:\/\/doi.org\/10.3389\/fendo.2024.1384956","DOI":"10.3389\/fendo.2024.1384956"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"[36] Lanzaro F, De Biasio D, Cesaro FG, Stampone E, Tartaglione I, Casale M, Bencivenga D, Marzuillo P, Roberti D. Childhood multiple endocrine neoplasia (MEN) syndromes: genetics, clinical heterogeneity and modifying genes. J Clin Med, 2024, 13(18):5510. https:\/\/doi.org\/10.3390\/jcm13185510","DOI":"10.3390\/jcm13185510"},{"key":"ref36","unstructured":"[37] Korbonits M, Hern\u00e1ndez-Ram\u00edrez LC. AIP familial isolated pituitary adenomas. 2012 Jun 21 [updated 2025 Nov 20]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A (eds). GeneReviews\u00ae [Internet]. University of Washington, Seattle, WA, USA, 1993-2025."},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"[38] Singeisen H, Renzulli MM, Pavlicek V, Probst P, Hauswirth F, Muller MK, Adamczyk M, Weber A, Kaderli RM, Renzulli P. Multiple endocrine neoplasia type 4: a new member of the MEN family. Endocr Connect, 2023, 12(2):e220411. https:\/\/doi.org\/10.1530\/EC-22-0411","DOI":"10.1530\/EC-22-0411"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"[39] Georgitsi M, Raitila A, Karhu A, van der Luijt RB, Aalfs CM, Sane T, Vierimaa O, M\u00e4kinen MJ, Tuppurainen K, Paschke R, Gimm O, Koch CA, G\u00fcndogdu S, Lucassen A, Tischkowitz M, Izatt L, Aylwin S, Bano G, Hodgson S, De Menis E, Launonen V, Vahteristo P, Aaltonen LA. Germline CDKN1B\/p27Kip1 mutation in multiple endocrine neoplasia. J Clin Endocrinol Metab, 2007, 92(8):3321-3325. https:\/\/doi.org\/10.1210\/jc.2006-2843","DOI":"10.1210\/jc.2006-2843"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"[40] Ruggeri RM, Benevento E, De Cicco F, Grossrubatscher EM, Hasballa I, Tarsitano MG, Centello R, Isidori AM, Colao A, Pellegata NS, Faggiano A. Multiple endocrine neoplasia type 4 (MEN4): a thorough update on the latest and least known men syndrome. Endocrine, 2023, 82(3):480-490. https:\/\/doi.org\/10.1007\/s12020-023-03497-2","DOI":"10.1007\/s12020-023-03497-2"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"[41] Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, Melmed S, Sakurai A, Tonelli F, Brandi ML; Endocrine Society. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab, 2012, 97(9):2990-3011. https:\/\/doi.org\/10.1210\/jc.2012-1230","DOI":"10.1210\/jc.2012-1230"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"[42] Thakker RV. Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4). Mol Cell Endocrinol, 2014, 386(1-2):2-15. https:\/\/doi.org\/10.1016\/j.mce.2013.08.002","DOI":"10.1016\/j.mce.2013.08.002"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"[43] Wu CC, Ekanem TI, Phan NN, Loan DTT, Hou SY, Lee KH, Wang CY. Gene signatures and prognostic analyses of the Tob\/BTG pituitary tumor-transforming gene (PTTG) family in clinical breast cancer patients. Int J Med Sci, 2020, 17(18):3112-3124. https:\/\/doi.org\/10.7150\/ijms.49652","DOI":"10.7150\/ijms.49652"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"[44] Sattler MGA, van Beek AP, Wolffenbuttel BHR, van den Berg G, Sluiter WJ, Langendijk JA, van den Bergh ACM. The incidence of second tumours and mortality in pituitary adenoma patients treated with postoperative radiotherapy versus surgery alone. Radiother Oncol, 2012, 104(1):125-130. https:\/\/doi.org\/10.1016\/j.radonc.2012.04.024","DOI":"10.1016\/j.radonc.2012.04.024"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"[45] Malaab SH, Pollak MN, Goodyer CG. Direct effects of Tamoxifen on growth hormone secretion by pituitary cells in vitro. Eur J Cancer, 1992, 28A(4-5):788-793. https:\/\/doi.org\/10.1016\/0959-8049(92)90116-j","DOI":"10.1016\/0959-8049(92)90116-J"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"[46] Lv T, Zhang Z, Yu H, Ren S, Wang J, Li S, Sun L. Tamoxifen exerts anticancer effects on pituitary adenoma progression via inducing cell apoptosis and inhibiting cell migration. Int J Mol Sci, 2022, 23(5):2664. https:\/\/doi.org\/10.3390\/ijms23052664","DOI":"10.3390\/ijms23052664"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"[47] Gebauer J, Higham C, Langer T, Denzer C, Brabant G. Long-term endocrine and metabolic consequences of cancer treatment: a systematic review. Endocr Rev, 2019, 40(3):711-767. https:\/\/doi.org\/10.1210\/er.2018-00092","DOI":"10.1210\/er.2018-00092"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"[48] Bayram F, Bitgen N, Donmez-Altuntas H, Cakir I, Hamurcu Z, Sahin F, Simsek Y, Baskol G. Increased genome instability and oxidative DNA damage and their association with IGF-1 levels in patients with active acromegaly. Growth Horm IGF Res, 2014, 24(1):29-34. https:\/\/doi.org\/10.1016\/j.ghir.2013.12.002","DOI":"10.1016\/j.ghir.2013.12.002"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"[49] Murphy N, Knuppel A, Papadimitriou N, Martin RM, Tsilidis KK, Smith-Byrne K, Fensom G, Perez-Cornago A, Travis RC, Key TJ, Gunter MJ. Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, and breast cancer risk: observational and Mendelian randomization analyses with \u223c430 000 women. Ann Oncol, 2020, 31(5):641-649. https:\/\/doi.org\/10.1016\/j.annonc.2020.01.066","DOI":"10.1016\/j.annonc.2020.01.066"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"[50] Watts EL, Fensom GK, Smith Byrne K, Perez-Cornago A, Allen NE, Knuppel A, Gunter MJ, Holmes MV, Martin RM, Murphy N, Tsilidis KK, Yeap BB, Key TJ, Travis RC. Circulating insulin-like growth factor-I, total and free testosterone concentrations and prostate cancer risk in 200 000 men in UK Biobank. Int J Cancer, 2021, 148(9):2274-2288. https:\/\/doi.org\/10.1002\/ijc.33416","DOI":"10.1002\/ijc.33416"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"[51] Strzelec M, Rolla M, Kuliczkowska-P\u0142aksej J, Ka\u0142u\u017cny M, S\u0142oka N, Wronowicz J, Bolanowski M, Jawiarczyk-Przyby\u0142owska A. Prevalence of neoplasms in patients with acromegaly - a single-center Polish study. J Clin Med, 2024, 13(22):6847. https:\/\/doi.org\/10.3390\/jcm13226847\"","DOI":"10.3390\/jcm13226847"}],"container-title":["Romanian Journal of Morphology and Embryology"],"original-title":[],"link":[{"URL":"https:\/\/rjme.ro\/RJME\/resources\/files\/660325511522.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T10:46:47Z","timestamp":1768819607000},"score":1,"resource":{"primary":{"URL":"https:\/\/rjme.ro\/archive\/66\/3\/8\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":51,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,12,12]]},"published-print":{"date-parts":[[2025,12,12]]}},"URL":"https:\/\/doi.org\/10.47162\/rjme.66.3.08","relation":{},"ISSN":["1220-0522","2066-8279"],"issn-type":[{"value":"1220-0522","type":"print"},{"value":"2066-8279","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]}}}